RespireRx Pharmaceuticals Inc (fka RSPI)

[COR lurker]

From one of the press releases:

"The Company expects to have further toxicological information available toward the end of this year, after completion of three-month toxicology trials in both monkeys and rats. "

So, they have completed 3 month tox studies and have more tox results to come.

The FDA dosing restriction was not a surprise to Stoll and it shouldn't be a surprise to us. The FDA is just trying to be as conservative as possible, which is the same reason the hold was introduced in the first place.